A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness

This study aimed to develop a microsimulation model to estimate the health effects, costs, and cost-effectiveness of public health and clinical interventions for preventing/managing type 2 diabetes. We combined newly developed equations for complications, mortality, risk factor progression, patient...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Value in health Ročník 26; číslo 9; s. 1372 - 1380
Hlavní autoři:	Hoerger, Thomas J., Hilscher, Rainer, Neuwahl, Simon, Kaufmann, Matthew B., Shao, Hui, Laxy, Michael, Cheng, Yiling J., Benoit, Stephen, Chen, Haiying, Anderson, Andrea, Craven, Tim, Yang, Wenya, Cintina, Inna, Staimez, Lisa, Zhang, Ping
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.09.2023
Témata:	Adult Cost-Benefit Analysis diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - therapy Glycated Hemoglobin Humans Internal Medicine microsimulation Middle Aged Outcome Assessment, Health Care probabilistic sensitivity analysis Public Health Quality-Adjusted Life Years risk equations United States - epidemiology United States probabilistic sensitivity analysis risk equations diabetes microsimulation
ISSN:	1098-3015, 1524-4733, 1524-4733
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!